Further resolution of non-T2 asthma subtypes from high-throughput sputum transciptomics data in U-BIOPRED
N. Zounemat Kermani (London, United Kingdom), S. Pavlidis (London, United Kingdom), M. Saqi (London, United Kingdom), Y. Guo (London, United Kingdom), P. Agapow (London, United Kingdom), C. Kuo (London, United Kingdom), M. Loza (Springhouse, United States of America), F. Baribaud (Springhouse, United States of America), A. Rowe (Springhouse, United States of America), A. Sousa (Stockley Park, United Kingdom), B. De Meulder (Lyon, France), D. Lefaudeux (Lyon, France), L. Fleming (London, United Kingdom), J. Corfield (Nottingham, United Kingdom), R. Knowles (Stevenage, United Kingdom), C. Auffray (Lyon, France), R. Djukanovic (Southampton, United Kingdom), P. Sterk (Amsterdam, Netherlands), I. Adcock (London, United Kingdom), F. Chung (London, United Kingdom)
Source: International Congress 2018 – Innovative therapies in asthma and COPD
Session: Innovative therapies in asthma and COPD
Session type: Poster Discussion
Number: 606
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Zounemat Kermani (London, United Kingdom), S. Pavlidis (London, United Kingdom), M. Saqi (London, United Kingdom), Y. Guo (London, United Kingdom), P. Agapow (London, United Kingdom), C. Kuo (London, United Kingdom), M. Loza (Springhouse, United States of America), F. Baribaud (Springhouse, United States of America), A. Rowe (Springhouse, United States of America), A. Sousa (Stockley Park, United Kingdom), B. De Meulder (Lyon, France), D. Lefaudeux (Lyon, France), L. Fleming (London, United Kingdom), J. Corfield (Nottingham, United Kingdom), R. Knowles (Stevenage, United Kingdom), C. Auffray (Lyon, France), R. Djukanovic (Southampton, United Kingdom), P. Sterk (Amsterdam, Netherlands), I. Adcock (London, United Kingdom), F. Chung (London, United Kingdom). Further resolution of non-T2 asthma subtypes from high-throughput sputum transciptomics data in U-BIOPRED. 606
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
High-throughput analysis of induced sputum from the U-BIOPRED study using novel proteomic and data mining approaches Source: Annual Congress 2013 –Origins and diagnosis of asthma Year: 2013
Sputum proteomics identifies distinct endotypes of exacerbations in bronchiectasis Source: Virtual Congress 2020 – Chronic lung diseases: novel methods, diagnostics and biomarkers Year: 2020
U-BIOPRED accessible handprint: combining omics platforms to identify stable asthma subphenotypes Source: International Congress 2018 – Biomarkers in COPD and asthma Year: 2018
Sputum proteomics and airway cell transcripts of current and ex-smokers with severe asthma in U-BIOPRED: an exploratory analysis Source: Eur Respir J, 51 (5) 1702173; 10.1183/13993003.02173-2017 Year: 2018
Integration of multi-omics datasets enables molecular classification of COPD Source: Eur Respir J, 51 (5) 1701930; 10.1183/13993003.01930-2017 Year: 2018
Metabolomic profiling differences among asthma, COPD and healthy controls: a LC-MS-based metabolomics analysis Source: International Congress 2019 – Evaluation of basic science in airway diseases Year: 2019
Integrating fingerprints: molecular phenotyping of severe asthma Source: International Congress 2015 – Fingerprinting severe asthma Year: 2015
Non-targeted integrative multi-omics approaches on sputum reveal potential diagnostic and monitoring biomarkers for respiratory diseases Source: International Congress 2017 – Novel molecular and genetic targets in COPD Year: 2017
Eicosanoids in asthma: multi-omics data interpretation Source: ERS Lung Science Conference 2016 Year: 2016
Genetics, genomics and a systems approach to asthma Source: Annual Congress 2008 - “Omics” and systems biology: the promise of future disease understanding Year: 2008
Deconvolution of the sputum transcriptome and methylome by quadratic programming in asthma and COPD Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease Year: 2021
Unbiased cluster analysis of severe asthma based on metabolomics by the U-BIOPRED electronic nose platform Source: Annual Congress 2013 –Asthma and COPD: diseases with different phenotypes Year: 2013
GC MS based untargeted metabolomics for understanding the pathophysiology of asthma COPD overlap (ACO) Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS) Year: 2018
“Integrative microbiomics” reveals a disrupted interactome in bronchiectasis exacerbations Source: Virtual Congress 2020 – Bronchiectasis: epidemiology, endotyping and therapy Year: 2020
Endotyping bronchiectasis through multi-omic profiling Source: Virtual Congress 2020 – Bronchiectasis: epidemiology, endotyping and therapy Year: 2020
The six-gene expression signature in whole sampled sputum provides clinically feasible inflammatory phenotyping of asthma Source: ERJ Open Res, 6 (1) 00280-2019; 10.1183/23120541.00280-2019 Year: 2020
A multi-omics approach to delineate sputum microbiome-associated asthma inflammatory phenotypes Source: Eur Respir J, 59 (1) 2102603; 10.1183/13993003.02603-2021 Year: 2022
A data management and analysis platform for RASP-UK multiomics clinical datasets Source: Virtual Congress 2021 – Exacerbations of chronic respiratory diseases, including SARS-CoV-2 Year: 2021